XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Sales:    
Total Sales $ 2,503,051 $ 3,915,389
Cost of Sales:    
Total Cost of Sales 1,863,697 2,835,798
Gross Profit (exclusive of depreciation shown separately below) 639,354 1,079,591
Operating Expenses:    
Research and Development 3,103,444 2,205,318
Selling and Marketing 2,023,435 1,303,430
General and Administrative 5,453,833 6,027,757
Depreciation and Amortization 422,931 517,412
Loss on Fixed Asset Disposal   83,908
Impairment of Patents and Trademarks 49,603 27,731
Total Operating Expenses 11,053,246 10,165,556
Loss From Operations (10,413,892) (9,085,965)
Other Income (Expense):    
Investment Income 6,280 7,838
Income and Other Taxes (47,632) (19,725)
Foreign Exchange Loss (50,757) (53,518)
Total Other Expense, Net (92,109) (65,405)
Loss Before Provision for Income Taxes (10,506,001) (9,151,370)
Net Loss $ (10,506,001) $ (9,151,370)
Basic Loss per Common Share $ (0.16) $ (0.17)
Diluted Loss per Common Share $ (0.16) $ (0.17)
Weighted-average Shares Outstanding - Basic 63,695,127 54,141,761
Weighted-average Shares Outstanding - Diluted 63,695,127 54,141,761
Sales of Products    
Sales:    
Total Sales $ 2,503,051 $ 3,805,170
Cost of Sales:    
Cost of Sales $ 1,863,697 2,819,971
Sales of Engineering Services    
Sales:    
Total Sales   110,219
Cost of Sales:    
Cost of Sales   $ 15,827